Name | Cvs Pharmacy #16872 |
---|---|
Organization Name | Connecticut Cvs Pharmacy Llc |
Location | 21 Broad St, Stamford, Connecticut 06901 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (203) 388-0038 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Hepatitis B-infected patients with significantly longer telomeres—the caps on the end of chromosomes that protect our genetic data— were found to have an increased risk of getting liver cancer compared to those with shorter ones, according to findings presented by researchers at Jefferson's Kimmel Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2012.
Democrats and Republicans are saying that they will need to compromise on a government-run public plan if they are to meet the deadline of having a bill on the Senate floor by the August recess, The Associated Press reports.
Allogeneic blood or marrow transplantation recipients are at a significantly higher risk of cognitive impairment in the years post-transplantation, according to a study published in Journal of Clinical Oncology.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that positive microplasmin Phase II trial results, evaluating the product for the nonsurgical treatment of vitreomacular adhesion, have been published in the July/August issue of the journal Retina.
› Verified 6 days ago
NPI Number | 1346262946 |
Organization Name | CONNECTICUT CVS PHARMACY LLC |
Doing Business As | CVS PHARMACY #16872 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 21 Broad St, Stamford, CT 06901 |
Phone Number | 203-388-0038 |
News Archive
Hepatitis B-infected patients with significantly longer telomeres—the caps on the end of chromosomes that protect our genetic data— were found to have an increased risk of getting liver cancer compared to those with shorter ones, according to findings presented by researchers at Jefferson's Kimmel Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2012.
Democrats and Republicans are saying that they will need to compromise on a government-run public plan if they are to meet the deadline of having a bill on the Senate floor by the August recess, The Associated Press reports.
Allogeneic blood or marrow transplantation recipients are at a significantly higher risk of cognitive impairment in the years post-transplantation, according to a study published in Journal of Clinical Oncology.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that positive microplasmin Phase II trial results, evaluating the product for the nonsurgical treatment of vitreomacular adhesion, have been published in the July/August issue of the journal Retina.
› Verified 6 days ago
News Archive
Hepatitis B-infected patients with significantly longer telomeres—the caps on the end of chromosomes that protect our genetic data— were found to have an increased risk of getting liver cancer compared to those with shorter ones, according to findings presented by researchers at Jefferson's Kimmel Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2012.
Democrats and Republicans are saying that they will need to compromise on a government-run public plan if they are to meet the deadline of having a bill on the Senate floor by the August recess, The Associated Press reports.
Allogeneic blood or marrow transplantation recipients are at a significantly higher risk of cognitive impairment in the years post-transplantation, according to a study published in Journal of Clinical Oncology.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that positive microplasmin Phase II trial results, evaluating the product for the nonsurgical treatment of vitreomacular adhesion, have been published in the July/August issue of the journal Retina.
› Verified 6 days ago
Cvs Pharmacy #00343 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 66 High Ridge Road, Stamford, Connecticut 06905 Phone: (203) 541-3972 | |
Cvs Pharmacy #01051 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 593 Newfield Ave, Stamford, Connecticut 06905 Phone: (203) 967-4600 | |
Cvs Pharmacy #01219 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 229 Hope St, Stamford, Connecticut 06906 Phone: (203) 921-1313 | |
Cvs Pharmacy #02258 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 537 Canal St, Stamford, Connecticut 06902 Phone: (203) 323-1293 | |
Cvs Pharmacy #03719 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 11 Forest St, Stamford, Connecticut 06901 Phone: (203) 363-0627 |